This opportunity is for an externship in clinical and translational sciences at Eli Lilly and Company for scholars, trainees, and investigators who are supported by the NCATS, Clinical and Translational Science Award (CTSA) Program. The externship at Eli Lilly, a large pharmaceutical company, will support the training and education of participants in techniques and principles needed for translational research. Education and training will be team oriented, and in areas of mutual interest for the trainee/scholar and Eli Lilly. Scientific, theoretical and practical knowledge will include an appreciation of translational and commercialization challenges in developing and bringing a biotechnology or pharmaceutical product to patients.

The key objective of this NCATS externship program is to enhance a translational scientists’ skill sets and competencies in clinical trial design, clinical pharmacology, toxicology, regulatory affairs and other areas critical to the drug development process. It is expected that at the end of this externship that participants (coming from academia) will understand the work, “language” and culture of another part of the translational ecosystem (industry) and contribute to the growth of a “bilingual” translational workforce that can promote cooperation and collaboration among academic and industry stakeholders.

Eligibility: This externship opportunity is open to:
- CTSA Program trainees, scholars or investigators supported by the CTSA Program hub award* funds, and
- who have a clinical doctoral degree (M.D. or Ph.D.) or its equivalent in biological or biomedical sciences, bioengineering or a related field, and
- who have a record of accomplishments in clinical and translational science research, and
- who have a keen interest in learning more about drug development and commercialization processes, and
- who are U.S. citizens or permanent residents of the United States.

Application Procedure:
1. Discuss your interests with your CTSA Program hub PI.
2. Discuss your interests with the NCATS point of contact prior to applying.
3. Apply: Please submit the following application package in PDF format:
- A cover letter signed by the applicant and the CTSA Program hub PI (1 page)
- A statement of research interests, your major achievements as a scientist, and a statement as to how this externship will benefit your research program and career development (no more than 3 pages)
- Indicate your top two project areas, if you were to be selected
- Your NIH biosketch
- Contact information for three references. One of the references must be the PI of the CTSA Program hub.

Applications are due on May 1, 2017.

All application materials should be submitted by the Authorized Organization Representative (AOR) via email to This email address is being protected from spambots. You need JavaScript enabled to view it. by May 1, 2017. Announcements will be made by early June with a target start date of July 15, 2017.

Please direct all inquiries to:
Joan Nagel, M.D., M.P.H.
National Center for Advancing Translational Sciences
Telephone: 301-827-2512
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.